Suresh Bugide

819 total citations
21 papers, 618 citations indexed

About

Suresh Bugide is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Suresh Bugide has authored 21 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Immunology. Recurrent topics in Suresh Bugide's work include Epigenetics and DNA Methylation (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Immune Cell Function and Interaction (5 papers). Suresh Bugide is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Immune Cell Function and Interaction (5 papers). Suresh Bugide collaborates with scholars based in United States, India and Canada. Suresh Bugide's co-authors include Narendra Wajapeyee, Michael R. Green, Romi Gupta, Bramanandam Manavathi, Rakesh Kumar, Radoslav Janoštiak, Parmanand Malvi, Ratna K. Vadlamudi, Vijay K. Gonugunta and Vasudevarao Penugurti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Endocrine Reviews.

In The Last Decade

Suresh Bugide

19 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suresh Bugide United States 12 428 196 159 128 91 21 618
Е. М. Slonimskaya Russia 15 320 0.7× 307 1.6× 173 1.1× 98 0.8× 78 0.9× 93 617
Carter J. Barger United States 14 517 1.2× 171 0.9× 153 1.0× 100 0.8× 45 0.5× 22 708
Neil MacLean Canada 17 588 1.4× 253 1.3× 155 1.0× 92 0.7× 34 0.4× 38 816
Zhihong Ai China 12 427 1.0× 117 0.6× 275 1.7× 88 0.7× 65 0.7× 23 648
Naila Chughtai Canada 9 326 0.8× 343 1.8× 106 0.7× 106 0.8× 68 0.7× 9 559
Matias Casás‐Selves United States 8 350 0.8× 175 0.9× 126 0.8× 75 0.6× 33 0.4× 9 549
Dorine Bellanger France 11 330 0.8× 201 1.0× 199 1.3× 103 0.8× 26 0.3× 15 586
Krista Meyer United States 10 582 1.4× 250 1.3× 76 0.5× 68 0.5× 54 0.6× 20 808
Kavitha Ramachandran United States 12 627 1.5× 124 0.6× 133 0.8× 142 1.1× 77 0.8× 22 780
Ryo Koyama‐Nasu Japan 17 659 1.5× 237 1.2× 170 1.1× 213 1.7× 64 0.7× 30 972

Countries citing papers authored by Suresh Bugide

Since Specialization
Citations

This map shows the geographic impact of Suresh Bugide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh Bugide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh Bugide more than expected).

Fields of papers citing papers by Suresh Bugide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh Bugide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh Bugide. The network helps show where Suresh Bugide may publish in the future.

Co-authorship network of co-authors of Suresh Bugide

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh Bugide. A scholar is included among the top collaborators of Suresh Bugide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh Bugide. Suresh Bugide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malvi, Parmanand, Suresh Bugide, Yvonne J. K. Edwards, et al.. (2025). PDE7A inhibition suppresses triple-negative breast cancer by attenuating de novo pyrimidine biosynthesis. Cell Reports Medicine. 6(9). 102356–102356.
2.
Bugide, Suresh, et al.. (2024). ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical models. iScience. 27(5). 109800–109800.
3.
Bugide, Suresh, Yvonne J. K. Edwards, Romi Gupta, Michael R. Green, & Narendra Wajapeyee. (2023). CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer. Proceedings of the National Academy of Sciences. 120(4). e2218118120–e2218118120. 10 indexed citations
4.
Penugurti, Vasudevarao, Suresh Bugide, Anita Kumari, et al.. (2023). HPIP and RUFY3 are noncanonical guanine nucleotide exchange factors of Rab5 to regulate endocytosis-coupled focal adhesion turnover. Journal of Biological Chemistry. 299(11). 105311–105311. 1 indexed citations
5.
Bugide, Suresh, et al.. (2022). Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth. iScience. 25(8). 104752–104752. 5 indexed citations
6.
Bugide, Suresh, et al.. (2022). Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis. iScience. 25(5). 104211–104211. 7 indexed citations
7.
Bugide, Suresh, et al.. (2022). UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress. NAR Cancer. 4(4). zcac035–zcac035. 11 indexed citations
8.
Bugide, Suresh, Romi Gupta, Michael R. Green, & Narendra Wajapeyee. (2021). EZH2 inhibits NK cell–mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner. Proceedings of the National Academy of Sciences. 118(30). 56 indexed citations
9.
Malvi, Parmanand, Deborah Della Manna, Eddy S. Yang, et al.. (2021). PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1. Oncogene. 40(13). 2448–2462. 30 indexed citations
10.
11.
Bugide, Suresh, Keshab R. Parajuli, Rudradip Pattanayak, et al.. (2020). Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R. Oncogenesis. 9(5). 44–44. 23 indexed citations
12.
Bugide, Suresh, et al.. (2020). Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells. Journal of Visualized Experiments. 9 indexed citations
13.
Gupta, Romi, Parmanand Malvi, Keshab R. Parajuli, et al.. (2020). KLF7 promotes pancreatic cancer growth and metastasis by up-regulating ISG expression and maintaining Golgi complex integrity. Proceedings of the National Academy of Sciences. 117(22). 12341–12351. 55 indexed citations
14.
Bugide, Suresh, et al.. (2020). Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells. Journal of Visualized Experiments. 1 indexed citations
15.
Bugide, Suresh, Radoslav Janoštiak, & Narendra Wajapeyee. (2018). Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells. Trends in cancer. 4(8). 553–566. 26 indexed citations
16.
Bugide, Suresh, Michael R. Green, & Narendra Wajapeyee. (2018). Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells. Proceedings of the National Academy of Sciences. 115(15). E3509–E3518. 120 indexed citations
17.
Bugide, Suresh, et al.. (2016). HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Cellular Oncology. 40(2). 133–144. 52 indexed citations
18.
19.
Manavathi, Bramanandam, et al.. (2012). Derailed Estrogen Signaling and Breast Cancer: An Authentic Couple. Endocrine Reviews. 34(1). 1–32. 93 indexed citations
20.
Manavathi, Bramanandam, Dennis Lo, Suresh Bugide, et al.. (2011). Functional Regulation of Pre-B-cell Leukemia Homeobox Interacting Protein 1 (PBXIP1/HPIP) in Erythroid Differentiation. Journal of Biological Chemistry. 287(8). 5600–5614. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Е. М. Slonimskaya Breakdown of academic impact, for papers by Carter J. Barger Breakdown of academic impact, for papers by Neil MacLean Breakdown of academic impact, for papers by Zhihong Ai Breakdown of academic impact, for papers by Naila Chughtai Breakdown of academic impact, for papers by Matias Casás‐Selves Breakdown of academic impact, for papers by Dorine Bellanger Breakdown of academic impact, for papers by Krista Meyer Breakdown of academic impact, for papers by Kavitha Ramachandran Breakdown of academic impact, for papers by Ryo Koyama‐Nasu
Rankless by CCL
2026